Long-term Outcomes of critically ill COVID-19 patients in the REMAP-CAP study

被引：0
|
作者：
Derde, Lennie P. G. [1 ]
Kerckhoffs, Monika C. [1 ]
机构：
[1] Univ Utrecht, UMC Utrecht, Afdeling Intens Care, Utrecht, Netherlands
来源：
INTENSIVIST | 2023年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：64
相关论文
共 50 条
  • [1] Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
    Higgins, Alisa M.
    Berry, Lindsay R.
    Lorenzi, Elizabeth
    Murthy, Srinivas
    McQuilten, Zoe
    Mouncey, Paul R.
    Al-Beidh, Farah
    Annane, Djillali
    Arabi, Yaseen M.
    Beane, Abi
    Van Bentum-Puijk, Wilma
    Bhimani, Zahra
    Bonten, Marc J. M.
    Bradbury, Charlotte A.
    Brunkhorst, Frank M.
    Burrell, Aiden
    Buzgau, Adrian
    Buxton, Meredith
    Charles, Walton N.
    Cove, Matthew
    Detry, Michelle A.
    Estcourt, Lise J.
    Fagbodun, Elizabeth O.
    Fitzgerald, Mark
    Girard, Timothy D.
    Goligher, Ewan C.
    Goossens, Herman
    Haniffa, Rashan
    Hills, Thomas
    Horvat, Christopher M.
    Huang, David T.
    Ichihara, Nao
    Lamontagne, Francois
    Marshall, John C.
    McAuley, Daniel F.
    McGlothlin, Anna
    McGuinness, Shay P.
    McVerry, Bryan J.
    Neal, Matthew D.
    Nichol, Alistair D.
    Parke, Rachael L.
    Parker, Jane C.
    Parry-Billings, Karen
    Peters, Sam E. C.
    Reyes, Luis F.
    Rowan, Kathryn M.
    Saito, Hiroki
    Santos, Marlene S.
    Saunders, Christina T.
    Serpa-Neto, Ary
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (01): : 39 - 51
  • [2] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
    Arabi, Yaseen M.
    Gordon, Anthony C.
    Derde, Lennie P. G.
    Nichol, Alistair D.
    Murthy, Srinivas
    Al Beidh, Farah
    Annane, Djillali
    Al Swaidan, Lolowa
    Beane, Abi
    Beasley, Richard
    Berry, Lindsay R.
    Bhimani, Zahra
    Bonten, Marc J. M.
    Bradbury, Charlotte A.
    Brunkhorst, Frank M.
    Buxton, Meredith
    Buzgau, Adrian
    Cheng, Allen
    De Jong, Menno
    Detry, Michelle A.
    Duffy, Eamon J.
    Estcourt, Lise J.
    Fitzgerald, Mark
    Fowler, Rob
    Girard, Timothy D.
    Goligher, Ewan C.
    Goossens, Herman
    Haniffa, Rashan
    Higgins, Alisa M.
    Hills, Thomas E.
    Horvat, Christopher M.
    Huang, David T.
    King, Andrew J.
    Lamontagne, Francois
    Lawler, Patrick R.
    Lewis, Roger
    Linstrum, Kelsey
    Litton, Edward
    Lorenzi, Elizabeth
    Malakouti, Salim
    McAuley, Daniel F.
    McGlothlin, Anna
    Mcguinness, Shay
    McVerry, Bryan J.
    Montgomery, Stephanie K.
    Morpeth, Susan C.
    Mouncey, Paul R.
    Orr, Katrina
    Parke, Rachael
    Parker, Jane C.
    INTENSIVE CARE MEDICINE, 2021, 47 (08) : 867 - 886
  • [3] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
    Yaseen M. Arabi
    Anthony C. Gordon
    Lennie P. G. Derde
    Alistair D. Nichol
    Srinivas Murthy
    Farah Al Beidh
    Djillali Annane
    Lolowa Al Swaidan
    Abi Beane
    Richard Beasley
    Lindsay R. Berry
    Zahra Bhimani
    Marc J. M. Bonten
    Charlotte A. Bradbury
    Frank M. Brunkhorst
    Meredith Buxton
    Adrian Buzgau
    Allen Cheng
    Menno De Jong
    Michelle A. Detry
    Eamon J. Duffy
    Lise J. Estcourt
    Mark Fitzgerald
    Rob Fowler
    Timothy D. Girard
    Ewan C. Goligher
    Herman Goossens
    Rashan Haniffa
    Alisa M. Higgins
    Thomas E. Hills
    Christopher M. Horvat
    David T. Huang
    Andrew J. King
    Francois Lamontagne
    Patrick R. Lawler
    Roger Lewis
    Kelsey Linstrum
    Edward Litton
    Elizabeth Lorenzi
    Salim Malakouti
    Daniel F. McAuley
    Anna McGlothlin
    Shay Mcguinness
    Bryan J. McVerry
    Stephanie K. Montgomery
    Susan C. Morpeth
    Paul R. Mouncey
    Katrina Orr
    Rachael Parke
    Jane C. Parker
    Intensive Care Medicine, 2021, 47 : 867 - 886
  • [4] Long-term Follow-up After Critical COVID-19 REMAP-CAP Revisited
    Barnett, Michael L.
    Sax, Paul E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (01): : 25 - 27
  • [5] LONG-TERM OUTCOMES OF CRITICALLY ILL COVID-19 PATIENTS: A SYSTEMATIC REVIEW
    Mazzochi, Katelyn
    De Silva, Sheraya
    Chan, Nicholas
    McGann, Erin
    Robertson, Tayla
    Hellings, Tahnee
    Hodgson, Carol
    Higgins, Alisa
    AUSTRALIAN CRITICAL CARE, 2024, 37 : S24 - S24
  • [6] Long-term characteristics and outcomes of septic critically ill patients with and without COVID-19
    Niebhagen, Felix
    Heubner, Lars
    Kirsch, Anna
    Gueldner, Andreas
    Held, Hanns-Christoph
    Schneider, Ralph
    Bodechtel, Ulf
    Mehrholz, Jan
    Koch, Thea
    Menk, Mario
    Spieth, Peter
    JOURNAL OF CRITICAL CARE, 2025, 85
  • [7] Short- and Long-Term Outcomes in Critically Ill Patients with COVID-19 and AKI
    Andrade, Juliana Alves Manhaes
    Meinerz, Gisele
    Rech, Eduardo Lange
    Palma, Raphael Hemann
    Dall Agnese, Marco Antonio Vinciprova
    Keitel, Elizete
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [8] Long-term consequences in critically ill COVID-19 patients: A prospective cohort study
    Schandl, Anna
    Hedman, Anders
    Lynga, Patrik
    Fathi Tachinabad, Sozan
    Svefors, Jessica
    Roel, Mari
    Geborek, Anne
    Andersson Franko, Mikael
    Soderberg, Marten
    Joelsson-Alm, Eva
    Darlington, Pernilla
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2021, 65 (09) : 1285 - 1292
  • [9] Long-term outcomes in critically ill patients who survived COVID-19: The NUTRICOVID observational cohort study
    Alvarez-Hernandez, J.
    Matia-Martin, P.
    Cancer-Minchot, E.
    CLINICAL NUTRITION, 2023, 42 (10) : 2029 - 2035
  • [10] Long term outcomes of critically ill COVID-19 pneumonia patients: early learning
    Claire McCue
    Richard Cowan
    Tara Quasim
    Kathryn Puxty
    Joanne McPeake
    Intensive Care Medicine, 2021, 47 : 240 - 241
12345